Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. 18 years of age or older 2. Diagnosed case of advanced solid cancers havingserum creatinine less than 0.6mg/dLand serum albumin reportswithin last 4 weeks of the visit. 3. Not planned for any disease-directed treatment. 4. Able to sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Not willing to participate in the study 2. Pregnant or breastfeeding patients. 3. Children under the age of 18 years. 4. Hematological malignancies. 5. Patients with recent laboratory values not available.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome of this study is Overall survival (OS) defined as the time period between the date of recruitment to the date of death from any cause. To assess the impact of serum creatinine levels (less than 0.6mg/dL) on the frequency of disease progression in cancer patients not on any disease-directed treatment.Timepoint: These patients will be followed up every 4 weeks till death or 12 months after recruitment of the last patient via details on the electronic medical record if the patient is visiting the hospital or telephonically to enquire about the general condition of the patient if no details are available on the electronic medical record. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome of this study is to assess impact on overall survival and median survival of patients not on any disease-directed treatment with serum creatinine of 0.4-0.6mg/dL. Timepoint: These patients will be followed up every 4 weeks till death or 12 months after recruitment of the last patient. | — |
Countries
India
Contacts
Public ContactDr Raghu Thota
Tata Memorial Hospital
Outcome results
None listed